<?xml version="1.0" encoding="UTF-8"?>
<p id="Par15">EKG and echocardiographic findings, in conjunction with biomarker elevation, help diagnose and predict prognosis in COVID-19 patients with cardiac involvement. Notably, data on the correlation between biomarkers, clinical manifestations and echocardiographic findings are lacking, and further study of this relationship may ultimately help in early risk stratification [
 <xref ref-type="bibr" rid="CR52">52</xref>]. Although case reports of myocarditis in COVID-19 patients exist, it is unclear whether the myocarditis is induced by the virus directly or results from an inflammatory response [
 <xref ref-type="bibr" rid="CR53">53</xref>]. A case of myopericarditis complicated by cardiac tamponade was also reported in the literature [
 <xref ref-type="bibr" rid="CR54">54</xref>]. Isolated hemorrhagic pericardial effusion with tamponade without the features of myocarditis has also been demonstrated [
 <xref ref-type="bibr" rid="CR55">55</xref>]. Recently, two cases have been reported with apparent Takotsubo syndrome in the setting of COVID infection [
 <xref ref-type="bibr" rid="CR56">56</xref>, 
 <xref ref-type="bibr" rid="CR57">57</xref>].
</p>
